| Literature DB >> 31262587 |
Nicolas Peyraud1, Darin Zehrung2, Courtney Jarrahian2, Collrane Frivold2, Toritse Orubu3, Birgitte Giersing4.
Abstract
Microarray patches (MAPs), also referred to as microneedle patches, are a novel methodology that have the potential to overcome barriers to vaccine delivery in low- and middle-income countries (LMICs), and transform the way that vaccines are delivered within immunization programs. The World Health Organization's Initiative for Vaccine Research and its partners are working to understand how MAPs could ease vaccine delivery and increase equitable access to vaccines in LMICs. Global stakeholders have been engaged to evaluate technical, economic, and programmatic challenges; to validate assumptions where possible; and to propose areas of focus to facilitate future vaccine-MAP product development. This report summarizes those learnings.Entities:
Keywords: Delivery; Microarray patches; Microneedle patches; Product development; Vaccine
Mesh:
Substances:
Year: 2019 PMID: 31262587 DOI: 10.1016/j.vaccine.2019.03.035
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641